Hutch News
Results per Page:
Study points toward progress on TB vaccines
High-tech analysis of correlates of protection may improve 100-year-old vaccine strategy
Coronavirus outbreak puts 'open science' under a microscope
Quick release of data could stop an epidemic, disrupt how research is reported
Promising HIV vaccine fails to show efficacy, trial halted
Based on earlier vaccine that was partly effective, researchers tried modified version
Hutch influenza experts assay the latest science
Flu shots remain your best bet for protection, but no guarantee against infection
Baiting for B cells: A clever new way to make an AIDS vaccine
Researchers fish for rare blood cells that can evolve into HIV blockers
Infectious Diseases Society to honor Dr. Michael Boeckh
Hutch virus expert to deliver John F. Enders Lecture at Washington, D.C., conference
An old HIV vaccine surprises researchers once again
Designed for a Thailand strain of the AIDS virus, it stirred stronger immunity in South Africa
Scientists gather in Seattle to share strategies for an HIV cure
Workshop focuses on ways to lower cost, broaden reach of gene therapy
Conference on gene therapy for HIV cures will highlight progress and challenges ahead
Dr. Robert Siliciano, keynote speaker, discovered why AIDS drugs alone cannot cure HIV
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Two Irish microbiologists find their way, together, to Seattle
Microbiome experts Drs. Susan Bullman and Christopher Johnston join Fred Hutch
Hutch Award Luncheon honors Stephen Piscotty, raises more than $575K for cancer research
Fred Hutch backers, baseball fans, scientists join at T-Mobile Park event
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Stephen Piscotty and a beloved parent’s legacy
A’s slugger to be honored at Hutch Award Luncheon for dedication to mom, research advocacy
Measles and cancer patients. What to do?
Measles seldom crossed paths with cancer survivors, but now that may change
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
Timmerman headed for the top, again, with friends
Hutch expedition to Kilimanjaro has already raised $1 million
Drs. Davidson and Galloway elected to Academy of Arts & Science
Scientists join one of the nation's oldest learned societies
Cancer prevention community mourns epidemiologist Dr. Alan Kristal
Pioneering researcher studied how diet can lower cancer risk